Zhen Ren Yang Zang Tang (True Man's Decoction to Nourish the Organs)

Actions

Indications

Western Uses:

• What is Zhen Ren Yang Zang Tang used for in modern practice?

  In modern practice, Zhen Ren Yang Zang Tang is referenced for chronic, deficiency-type diarrheal conditions — practitioners have traditionally applied its warming, astringing, tonifying pattern to presentations resembling ulcerative colitis in a quiescent or deficiency-cold phase, irritable bowel syndrome with diarrhea, and rectal prolapse, contexts where Western medicine recognizes chronic loose stools, mucosal inflammation, or pelvic-floor weakness.

  These biomedical correlates are offered as a reference to the formula’s traditional use, not as a claim that it treats any diagnosed disease. Contemporary study (see research) has so far focused on ulcerative colitis models and a small pool of Chinese clinical trials; it does not establish the formula as a treatment for any Western diagnosis. Any use for a diagnosed condition belongs with a qualified practitioner and appropriate medical care — and, given the Ying Su Ke content, under professional supervision only (see cautions).

  Source: traditional-use correlates summarized from multiple online sources; reference only, not a treatment claim.

Originally Appeared In:

• Imperial Grace Formulary of the Tai Ping Era (Tai Ping Hui Min He Ji Ju Fang)

Notes:

• How does Zhen Ren Yang Zang Tang compare to other astringent diarrhea formulas, and how is it modified?

  Zhen Ren Yang Zang Tang is one of the strongest astringent formulas in the Chinese herbal repertoire because it is the only widely referenced classical formula built around Ying Su Ke — other Spleen-Kidney formulas for chronic diarrhea rely on gentler astringents and stronger warming instead.

  • vs Si Shen Wan (Four Miracle Pill): Si Shen Wan targets “daybreak diarrhea” from Kidney yang deficiency alone, using Bu Gu Zhi, Wu Zhu Yu, Rou Dou Kou, and Wu Wei Zi without any poppy husk — a milder, more purely warming-astringent approach for a narrower pattern.
  • vs Tao Hua Tang (Peach Blossom Decoction): Tao Hua Tang warms and binds for cold-type dysentery with a simpler three-herb structure (Chi Shi Zhi, Gan Jiang, Geng Mi) and no qi-and-blood tonics — suited to a less depleted, more acute-cold presentation than the chronic, deficient picture Zhen Ren Yang Zang Tang addresses.

  Key modifications multiple online sources: for pronounced rectal prolapse, add Huang Qi and Sheng Ma to lift sunken qi, borrowing the strategy of Bu Zhong Yi Qi Tang; where residual heat signs remain, remove Rou Gui and add Huang Lian to clear lingering damp-heat without abandoning the overall warming-astringent strategy.

  Source: multiple online sources (modifications, related-formula comparison); formula identity cross-checked against standard classical-formula references for Si Shen Wan and Tao Hua Tang composition.

Clinical Studies & Research:

• Is there modern research on Zhen Ren Yang Zang Tang?

  Yes, though it is limited to a handful of studies focused on ulcerative colitis — one meta-analysis of Chinese clinical trials plus a network-pharmacology analysis, and one earlier rat model. A 2021 meta-analysis pooling 5 randomized controlled trials (356 patients total, all conducted in China) found the total effective rate and recovery rate for ulcerative colitis significantly higher with Zhenren Yangzang decoction than control treatment, alongside reductions in the inflammatory cytokines IL-6 and TNF-α and fewer adverse reactions in the treatment group. The same paper's network-pharmacology analysis identified 169 active compounds and 187 formula-related target genes overlapping with ulcerative-colitis-associated genes, enriched in IL-17 and AGE-RAGE inflammatory signaling pathways.

  • Ulcerative colitis (clinical meta-analysis + network pharmacology): total effective rate pooled OR 3.11 (95% CI 1.50–6.46); recovery rate pooled OR 3.32 (95% CI 1.91–5.78); IL-6 and TNF-α reductions; fewer adverse reactions than control (PMID 34992665; PMC 8727130; DOI 10.1155/2021/4512755).
  • Ulcerative colitis (rat model, preclinical): in TNBS-induced colitis in rats, oral Zhenrenyangzang decoction (2, 4, or 8 g/kg/day for 8 days) reduced colonic NF-κB and p38MAPK expression and increased TLR2, promoting recovery from colitis comparable to standard sulfasalazine therapy (PMID 26629011; PMC 4658900).

  Sources: PubMed 34992665 / PMC 8727130 (DOI 10.1155/2021/4512755); PubMed 26629011 / PMC 4658900. Research context on ulcerative colitis models only, not a therapeutic claim for the formula's classical dysentery/diarrhea indication; direct clinical trial evidence for chronic diarrhea (as opposed to ulcerative colitis) was not found and is not claimed.